期刊文献+

Sphk1基因对人乳腺癌MCF-7细胞增殖、凋亡和迁移能力的影响 被引量:2

Sphk1 interference suppresses proliferation,apoptosis and migration in human MCF-7 breast cancer cells
下载PDF
导出
摘要 目的通过抑制鞘氨醇激酶-1(sphingosine kinase-1,Sphk1)基因表达,观察其对人乳腺癌MCF-7细胞增殖、凋亡和迁移能力的影响。方法使用脂质体2000将化学合成的靶向Sphk1基因的小干扰RNA(small interfering RNA,siRNA)转入人乳腺癌MCF-7细胞。使用流式细胞术(FCM)检测转染效率,荧光定量RT-PCR(qRT-PCR)和Western blot法检测Sphk1的mRNA和蛋白表达水平。利用CCK-8法检测细胞的增殖能力,流式细胞术检测细胞凋亡,Transwell小室法检测细胞迁移能力。结果 Sphk1 siRNA转染效率达89%。转染siRNA后,MCF-7细胞的Sphk1 mRNA和蛋白表达水平均明显下降,以siRNA-2效果最为显著(P<0.01)。转染Sphk1 siRNA-2后,MCF-7细胞的增殖和迁移能力明显下降,凋亡细胞比例增加,以上差异均具有统计学意义(P<0.05)。结论干扰Sphk1基因表达可有效抑制MCF-7细胞的增殖、迁移能力,同时诱导细胞发生凋亡,Sphk1基因可能成为一个潜在的乳腺癌治疗靶标。 Objective To investigate the effect of down-regulating sphingosine kinase-1 (Sphk1) on the proliferation, apoptosis and migration in human breast cancer MCF-7 cell line. Methods The siRNA against Sphk1 was chemically synthesized and then transfected into MCF-7 cells using Lipofectamine 2000. Transfection efficiency was examined by flow cytometry ( FCM ) and the expression levels of Sphk1 mRNA and protein were determined by real-time fluorescent quantitative PCR and Western blotting. Cell proliferation and cell apoptosis was assessed by CCK-8 assay and FCM respectively. Cell migration was measured by transwell assay. Results The efficiency of siRNA transfection into human MCF-7 cells were 89%. The siRNA against sphkl gene significantly reduced the mRNA and protein expression of Sphk1 in MCF-7 cells ( P 〈 0.05 ). The siRNA-2 showed most significant effect( P 〈0.01 ). The MCF-7 ceils transfected with Sphk1 siRNA-2 showed a significant decrease of cell proliferation and migration compared to the control cells. Moreover, significant increase of proportion of apoptotic cells were detected in the transfected cells (P 〈 0. 05 ). Conclusion Sphk1 knockdown in breast cancer cells effectively inhibits the proliferation and migration and induces the apoptosis in MCF-7 ceils. Sphk1 may become a potential target for gene therapy of breast cancer.
出处 《第三军医大学学报》 CAS CSCD 北大核心 2012年第21期2141-2144,共4页 Journal of Third Military Medical University
基金 国家自然科学基金(81072156)~~
关键词 乳腺肿瘤 RNA干扰 SIRNA Sphk1 breast cancer RNA interference siRNA Sphkl
  • 相关文献

参考文献18

  • 1Clark C J, Whang S, Paige K T. Incidence of precancerous lesions in breast reduction tissue: a pathologic review of 562 consecutive patients [ J]. Plast Reconstr Surg, 2009, 124(4) : 1033 -1039.
  • 2Graesslin O, Antoine M, Chopier J, et al. Histology after lumpeetomy in women with epithelial atypia on stereotactic vacuum-assisted breast biopsy[J]. Eur J Surg Oncol, 2010, 36(2) : 170 -175.
  • 3Pappu R, Schwab S R, Comelissen I, et al. Promotion of lymphocyte egress into blood and lymph by distinct sources of sphingosine-l-phosphate[J]. Science, 2007, 316(5822): 295-298.
  • 4Okada T, Kajimoto T, Jabangeer S, et al. Sphingosine kinase/sphingosine 1-phosphate signalling in central nervous system [ J ]. Cell Signal, 2009, 21(1): 7-13.
  • 5Ader I, Malavaud B, CuviUier O. When the sphingosine kinase 1/ sphingosine 1-phosphate pathway meets hypoxia signaling: new targets for cancer therapy[ J ]. Cancer Res, 2009, 69 (9) : 3723 - 3726.
  • 6Marsolais D, Rosen H. Chemical modulators of sphingosine-l-phosphate receptors as barrier-oriented therapeutic molecules [ J ]. Nat Rev Drug Discov, 2009, 8 (4) : 297 - 307.
  • 7张淼,郭燕丽,王洛夫,李彦,李锐.靶向于雄激素受体的siRNA筛选及效能评价[J].第三军医大学学报,2011,33(23):2459-2462. 被引量:1
  • 8Takabe K, Paugh S W, Milstien S, et al. " Inside-out" signaling of sphingosine-l-phosphate: therapeutic targets [ J ]. Pharmacol Rev, 2008, 60(2) : 181 -195.
  • 9Pyne N J, Pyne S. Sphingosine 1-phosphate and cancer[ J]. Nat Rev Cancer, 2010, 10(7) : 489 -503.
  • 10Guan H, Song L, Cai J, et al. Sphingosine kinase 1 regulates the Akt/FOXO3a/Bim pathway and contributes to apoptosis resistance in glioma cells[J]. PLoS One, 2011, 6(5) : e19946.

二级参考文献26

  • 1韦娜,糜漫天,张乾勇,王斌,袁家林.不同膳食脂肪酸对大鼠乳腺癌组织脂肪酸组成和脂代谢基因表达的影响[J].营养学报,2007,29(2):122-126. 被引量:10
  • 2Edlich RF,Cross CL,Wack CA,et al.Breast cancer and ovarian cancer genetics:an update.J Environ Pathol Toxicol Oncol,2008,27:245-256.
  • 3Pappu R,Schwab SR,Cornelissen I,et al.Promotion of lymphocyte egress into blood and lymph by distinct sources of sphingosine-1-phosphate.Science,2007,316:295-298.
  • 4Tavassoli FA,Devilee P.World Health Organization classification of tumors,pathology and genetics,tumors of breast and female genital organs.Lyon:IARC Press,2003.
  • 5Okada T,Kajimoto T,Jahangeer S,et al.Sphingosine kinase/sphingosine 1-phosphate signalling in central nervous system.Cell Signal,2009,21:7-13.
  • 6Shida D,Takabe K,Kapitonov D,et al.Targeting SPHK1 as a new strategy against cancer.Curr Drug Targets,2008,9:662-673.
  • 7Oskouian B,Saba J.Sphingosine-1-phosphate metabolism and intestinal tumorigenesis:lipid signaling strikes again.Cell Cycle,2007,6:522-527.
  • 8Venkataraman K,Thangada S,Michaud J,et al.Extracellular export of sphingosine kinase-la contributes to the vascular SIP gradient.Biochem J,2006,397:461-471.
  • 9Kohno M,Momoi M,Oo ML,et al.Intracellular role for sphingosine kinase 1 in intestinal adenoma cell proliferation.Mol Cell Biol,2006,26:7211-7223.
  • 10Nava VE,Hobson JP,Murthy S,et al.Sphingosine kinase type 1 promotes estrogen-dependent tumorigenesis of breast cancer MCF-7 cells.Exp Cell Res,2002,281:115-127.

共引文献3

同被引文献26

  • 1Kohama T, Olivera A, Edsall L, et al. Molecular cloning and functional characterization of murine sphingosine kinase [J]. J Biol Chern, 1998, 273 (37) : 23722 - 23728.
  • 2Ogretmen B, Hannun Y A. Biologically active sphingolipids in cancer pathogenesis and treatment[J] . Nat Rev Cancer, 2004, 4(8): 604- 616.
  • 3French K J, Schrecengost R S, Lee B D, et al: Discovery and evaluation of inhibitors of human sphingosine kinase [J]. Cancer Res, 2003, 63 (I8) : 5962 - 5969.
  • 4Sarkar S, Maceyka M, Hait N C, et al. Sphingosine kinase 1 is required for migration, proliferation and survival of MCF-7 human breast cancer cells[J]. FEBS Lett, 2005, 579(24): 5313 -5317.
  • 5Pyne N J, Pyne S. Sphingosine I-phosphate and cancer [J]. Nat Rev Cancer, 2010,10(7): 489 -503.
  • 6Li J, Guan H Y, Gong L Y, et al. Clinical significance of sphingosine kinase-l expression in human astrocytomas progression and overall patient survival[J]. Clin Cancer Res, 2008,14(21): 6996 -7003.
  • 7Kawamori T, Kaneshiro T, Okumura M, et al. Role for sphingosine kinase 1 in colon carcinogenesis [J]. F ASEB J, 2009, 23 ( 2) : 405 - 414.
  • 8Akao Y, Banno Y, Nakagawa Y, et al. High expression of sphingosine kinase 1 and SI P receptors in chemotherapy-resistant prostate cancer PC3 cells and their camptothecin-induced up-regulation [J]. Biochem Biophys Res Commun, 2006, 342(4): 1284 -1290.
  • 9Liu S Q, SU Y J, Qin M B, et al. Sphingosine kinase 1 promotes tumor progression and confers malignancy phenotypes of colon cancer by regulating the focal adhesion kinase pathway and adhesion moleculea] ] ]. Int J Oncol, 2013,42(2) : 617 -626.
  • 10Li W, Yu C P, Xia J T, et al. Sphingosine kinase 1 is associated with gastric cancer progression and poor survival of patients [J]. Clin Cancer Res, 2009, 15 (4) : 1393 - 1399.

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部